Howard Hassman

Howard Hassman has an extensive work experience in the field of scientific research and leadership roles. Howard currently serves as the Chief Scientific Officer at CenExel since June 2022. Howard was previously the CEO at Apex Innovation Sciences starting from October 2019. Before that, they held the position of Chief Scientific Officer at Hassman Research Institute from January 2016. Earlier in their career, Howard founded CRI Lifetree and served as the Chief Scientific Officer, which started in 1998. Additionally, they had a role as the Senior Vice President at Pharmaceutical Research Associates, Inc. from December 2013 to October 2015.

Howard Hassman received their Bachelor of Applied Science (B.A.Sc.) degree in Pre-Medicine/Pre-Medical Studies from Fairleigh Dickinson University in 1978. Howard then pursued a Master of Engineering (M.Eng.) in Biomedical/Medical Engineering from Drexel University, completing it in 1979. Howard Hassman eventually obtained their Doctor of Osteopathic Medicine (DO) from the Philadelphia College of Osteopathic Medicine in 1983.